Dr John Martin Turner Iii, DDS | |
1800 Eye St Nw, Jm Turner #803, Washington, DC 20006 | |
(202) 393-3880 | |
Not Available |
Full Name | Dr John Martin Turner Iii |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 1800 Eye St Nw, Washington, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033120209 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 4623 (District Of Columbia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Martin Turner Iii, DDS 9132 Vendome Dr, Jm Turner, Bethesda, MD 20817 Ph: (301) 365-3832 | Dr John Martin Turner Iii, DDS 1800 Eye St Nw, Jm Turner #803, Washington, DC 20006 Ph: (202) 393-3880 |
News Archive
Researchers at the University of Pittsburgh School of Medicine and the University of Toronto have uncovered the first molecular steps that lead to immune system activation and eventual rejection of a transplanted organ.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with the PBS Newshour, reports: "The future of Medicaid - the state-federal workhorse of the nation's health system that provides health coverage to the poorest and sickest Americans - hangs in the balance on Election Day. President Barack Obama and Republican nominee Mitt Romney have vastly different approaches to the program."
PrognosDx Health, Inc. announced today that in an independent research study published online in the Journal of Clinical Oncology, cellular levels of histone modifications define previously unrecognized subsets of patients with pancreatic cancer with distinct epigenetic phenotypes and clinical outcomes.
Nordion Inc., a leading provider of products and services to the global health science market, today shared results from the first multi-site, Phase II clinical trial to evaluate TheraSphere® for treatment of metastatic liver cancer.
Newron Pharmaceuticals S.p.A. ("Newron"), a research and development company focused on novel CNS and pain therapies, and its partner Zambon S.p.A., a pharmaceutical company strongly committed to the respiratory, primary care and CNS therapeutic areas, presented results from SETTLE Phase III study with safinamide at the 17th International Congress of Parkinson's disease and Movement Disorders, taking place from June 16 to 20, 2013, at the Sydney Convention and Exhibition Centre, Sydney, Australia.
› Verified 7 days ago
Dr. Hassan E Chehayeb, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4201 Massachusetts Ave Nw, 1040c, Washington, DC 20016 Phone: 202-244-3902 Fax: 202-244-6547 | |
Dr. Siamak Sy Majidi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3239 N St Nw Apt 12, Washington, DC 20007 Phone: 240-418-6103 | |
Dr. Cecile Elaine Skinner, DDS., PH.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 600 W St Nw, Washington, DC 20059 Phone: 202-806-0462 Fax: 202-806-0303 | |
Tomell Lemart Dubose, Dentist Medicare: Not Enrolled in Medicare Practice Location: 5437 Connecticut Ave Nw, 203, Washington, DC 20015 Phone: 202-364-6550 Fax: 202-364-7297 | |
Dr. Dominicque Blanche Gray, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 3946 Minnesota Ave Ne, Washington, DC 20019 Phone: 202-397-1033 | |
Dr. Manasi Supekar, Dentist Medicare: Medicare Enrolled Practice Location: 3521 12th St Ne, Washington, DC 20017 Phone: 020-245-0592 | |
Dr. Chi-lan Pham, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 4200 Wisconsin Ave Nw Ste 240, Washington, DC 20016 Phone: 202-545-7200 |